Moving from theory to research to practice: Implementing an effective dyadic intervention to improve antiretroviral adherence for clinic patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue SUPPL. 1, 2006, Pages

  Remien, Robert H ^a   Stirratt, Michael J ^a   Dognin, Joanna ^b   Day, Emily ^c   El Bassel, Nabila ^d   Warne, Patricia ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c NEW SCHOOL FOR SOCIAL RESEARCH   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Antiretroviral adherence; Couples; HIV; Intervention; Social action theory; Social support

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG EFFICACY; EMPIRICAL RESEARCH; HEALTH BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; SOCIAL SUPPORT; THEORETICAL STUDY; TREATMENT OUTCOME;

ANTI-HIV AGENTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; SEXUAL PARTNERS;

EID: 33845355393     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000248340.20685.7d     Document Type: Article

References (112)

1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
2. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357-366.
3. Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33:1417-1423.
4. Walsh JC, Pozniak AL, Nelson MR, et al. Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance. J Acquir Immune Defic Syndr. 2002;30:278-287.
5. King MS, Brun SC, Kempf DJ. Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir. J Infect Dis. 2005;191:2046-2052.
6. Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191:339-347.
7. Bangsberg DR, Acosta E, Gupta R, et al. Differences in protease and non-nucleoside reverse transcriptase inhibitor adherence-resistance relationships are explained by virologic fitness. AIDS. 2005;20:223-231.
8. Bangsberg DR, Porco TC, Kagay C, et al. Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates. J Infect Dis. 2004;190:162-165.
9. Bangsberg DR, Charlebois ED, Grant RM, et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS. 2003;17:1925-1932.
10. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181-1183.
11. Hogg RS, Heath K, Bangsberg D, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16:1051-1058.
12. de Olalla G, Knobel H, Carmona A, et al. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;30:105-110.
13. Maggiolo F, Ravasio L, Ripamonti D, et al. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis. 2005;40:158-163.
14. Bangsberg DR, Weiser S, Guzman D, et al. 95% Adherence is not necessary for viral suppression to <400 copies/mL in the majority of individuals on NNRTI regimens. Presented at: 12th Conference on Retroviruses and Opportunistic Infections; 2005; Boston.
15. Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19:807-814.
16. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(Suppl):S123-S127.
17. Remien RH, Hirky AE, Johnson MO, et al. Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities. AIDS Behav. 2003;1:61-72.
18. Berkman LF. The relationship of social networks and social support to morbidity and mortality. In: Cohen S, Symy SL, eds. Social Support and Health. Orlando, FL: Academic Press; 1985:241-262.
19. Brecht ML, Dracup K, Moser DK, et al. The relationship of marital quality and psychosocial adjustment to heart disease. J Cardiovasc Nurs. 1994;9:74-85.
20. Cohen S. Psychosocial models of the role of social support in the etiology of physical disease. Health Psychol. 1988;7:269-297.
21. DiMatteo MR, Hays R. Social support and serious illness. In: Gottlieb BA, ed. Social Networks and Social Support in Community Mental Health. Beverly Hills, CA: Sage; 1981:207-218.
22. Ell K, Nishimoto R, Mediansky L, et al. Social relations, social support and survival among patients with cancer. J Psychosom Res. 1992;36:531-541.
23. Kaplan RM, Toshima MT. The function effects of social relationships on chronic illnesses and disability. In: Sarason IG, Sarason BR, Pierce GR, eds. Social Support: An Interactional View. New York: Wiley; 1990:427-453.
24. King KB, Reis HT, Porter LA, et al. Social support and long-term recovery from coronary artery surgery: effects on patients and spouses. Health Psychol. 1993;12:56-63.
25. Lewis MA, Butterfield RA, Darbes LA, et al. The conceptualization and assessment of health-related social control. J Soc Pers Relat. 2004;21:669-687.
26. Littlefield CH, Rodin GM, Murray MA, et al. Influence of functional impairment and social support on depressive symptoms in persons with diabetes. Health Psychol. 1990;9:737-749.
27. Maunsell E, Brisson J, Deschenes L. Social support and survival among women with breast cancer. Cancer. 1995;76:631-637.
28. Umberson D. Family status and health behaviors: social control as a dimension of social integration. J Health Soc Behav. 1987;28:306-319.
29. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23:207-218.
30. Haynes RB. Strategies for improving compliance: a methodological analysis and review. In: Sackett DC, Haynes RB, eds. Compliance with Therapeutic Regimens. Baltimore, MD: Johns Hopkins University Press; 1976:69-82.
31. Erdman RA, Horstman L, Van Domburg RT, et al. Compliance with the medical regimen and partner's quality of life after heart transplantation. Qual Life Res. 1993;2:205-212.
32. Somer E, Tucker CM. Patient life engagement, spouse marital adjustment, and dietary compliance of hemodialysis patients. J Compliance Health Care. 1988;3:57-65.
33. Steidl JH, Finkelstein OF, Wexler JP, et al. Medical condition, adherence to treatment regimens, and family functioning: their interactions in patients receiving long-term dialysis treatment. Arch Gen Psychiatry. 1980;37:1025-1027.
34. Evans RL, Bishops DS, Matlock AL, et al. Family interaction and treatment adherence after stroke. Arch Phys Med Rehabil. 1987;68:513-517.
35. Catz SL, Kelly JA, Bogart LM, et al. Patterns, correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19:124-133.
36. Glass TR, De Geest S, Weber R, et al. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2006;41:385-392.
37. Godin G, Cote J, Naccache H, et al. Prediction of adherence to antiretroviral therapy: a one-year longitudinal study. AIDS Care. 2005;17:493-504.
38. Gonzalez JS, Penedo FJ, Antoni MH, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol. 2004;23:413-418.
39. Gordillo V, del Amo J, Soriano V, et al. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13:1763-1769.
40. Malcolm SE, Ng JJ, Rosen RK, et al. An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care. 2003;15:251-261.
41. Morse EV, Simon PM, Coburn M, et al. Determinants of subject compliance within an experimental anti-HIV drug protocol. Soc Sci Med. 1991;10:1161-1167.
42. Murphy DA, Marelich WD, Hoffman D, et al. Predictors of antiretroviral adherence. AIDS Care. 2004;16:471-484.
43. Murri R, Ammassari A, Gallicano K, et al. Patient-reported nonadherence to HAART is related to protease inhibitor levels. J Acquir Immune Defic Syndr. 2000;24:123-128.
44. Power R, Koopman C, Volk J, et al. Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons. AIDS Patient Care STDS. 2003;17:245-252.
45. Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29:824-830.
46. Blaney NT, Fernandez I, Ethier KA, et al. Psychosocial and behavioral correlates of depression among HIV-infected pregnant women. AIDS Patient Care STDS. 2004;18:405-415.
47. Chesney MA, Chambers DB, Taylor JM, et al. Social support, distress, and well-being in older men living with HIV infection. J Acquir Immune Defic Syndr. 2003;33(Suppl):S185-S193.
48. Clingerman E. Physical activity, social support, and health-related quality of life among persons with HIV disease. J Community Health Nurs. 2004;21:179-197.
49. Heckman TG, Anderson ES, Sikkema KJ, et al. Emotional distress in nonmetropolitan persons living with HIV disease enrolled in a telephone-delivered coping improvement group intervention. Health Psychol. 2004;23:94-100.
50. Kalichman SC, DiMarco M, Austin J, et al. Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. J Behav Med. 2003;26:315-332.
51. Kelly JA, Murphy DA, Bahr GR, et al. Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. Am J Psychiatry. 1993;150:1679-1686.
52. Leserman J, Jackson ED, Petitto JM, et al. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med. 1999;61:397-406.
53. Prado G, Feaster DJ, Schwartz SJ, et al. Religious involvement, coping, social support, and psychological distress in HIV-seropositive African American mothers. AIDS Behav. 2004;8:221-235.
54. Safren SA, Radomsky AS, Otto MW, et al. Predictors of psychological well-being in a diverse sample of HIV-positive patients receiving highly active antiretroviral therapy. Psychosomatics. 2002;43:478-485.
55. Swindells S, Mohr J, Justis JC, et al. Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. Int J STD AIDS. 1999;10:383-391.
56. Deleted in Proof.
57. Wills TA, Fegan MF. Social networks and social support. In: Baum A, Revenson TA, Singer JE, eds. Handbook of Health Psychology. Mahwah, NJ: Lawrence Erlbaum; 2001: 209-234.
58. Levy RL. Social support and compliance: a selective review and critique of treatment integrity and outcome measurement. Soc Sci Med. 1983;17:1329-1338.
59. Meichenbaum D, Turk DC. Facilitating Treatment Adherence: A Practitioner's Guidebook. New York: Plenum Press; 1987.
60. Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25:74-81.
61. Weaver KE, Llabre MM, Duran RE, et al. A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART). Health Psychol. 2005;24:385-392.
62. Johnson MO, Catz SL, Remien RH, et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project. AIDS Patient Care STDS. 2003;17:645-656.
63. Coyne JC, DeLongis A. Going beyond social support: the role of social relationships in adaptation. J Consult Clin Psychol. 1986;54:454-460.
64. Coyne JC, Ellard JH, Smith DAF. Social support, interdependence and the dilemmas of helping. In: Sarason IG, Sarason BR, Pierce GR, eds. Social Support: An Interactional View. New York:Wiley; 1990:129-149.
65. Coyne JC, Smith DAF. Couples coping with a myocardial infarction: a contextual perspective on wives'distress. J Pers Soc Psychol. 1991;61:404-412.
66. Coyne JC, Smith DAF. Couples coping with a myocardial infarction: contextual perspective on patient self-efficacy. J Fam Psychol. 1994;8:43-54.
67. Anderson CM, Griffin S, Rossi A, et al. A comparative study of the impact of education vs. process groups for families of patients with affective disorders. Fam Process. 1986;25:185-205.
68. Barter JT, Queirolo JF, Ekstrom SP. A psychoeducational approach to educating chronic mental patients for community living. Hosp Community Psychiatry. 1984;35:793-797.
69. Jacob M, Frank E, Kupfer DJ, et al. A psychoeducational workshop for depressed patients, family, and friends: description and evaluation. Hosp Community Psychiatry. 1987;38:968-972.
70. Rea MM, Miklowitz DJ, Tompson MC, et al. Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. J Consult Clin Psychol. 2003;71:482-492.
71. Cutter CG, Cutter HS. Adult children of alcoholics. J Stud Alcohol. 1987;48:29-32.
72. Wermuth L, Scheidt S. Enlisting family support in drug treatment. Fam Process. 1986;25:25-33.
73. Parker T, Hill JW, Miller G. Multiple family therapy: evaluating a group experience for mentally retarded adolescents and their families. Fam Ther. 1987;14:43-51.
74. Edelstein J, Linn MW. The influence of family on control of diabetes. Soc Sci Med. 1985;21:541-545.
75. Pfeiffer SI, Gerber PJ, Reiff HB. Family oriented intervention with the learning disabled child. Journal of Reading, Writing, and Learning Disabilities International. 1985;1:63-99.
76. Wilchesky M, Reynolds T. The socially deficient LD child in context: a systems approach to assessment and treatment. J Learn Disabil. 1986;19:411-415.
77. Mitrowski CA. Social work intervention with geriatric cancer patients and their children. Soc Casework. 1985;66:242-245.
78. Nathanson MN, Monaco GP. Meeting the educational and psychosocial needs produced by diagnosis of pediatric/adolescent cancer. Health Educ Q. 1984;10(Suppl):67-75.
79. Harvey MA. Toward a dialogue between the paradigms of family therapy and deafness. Am Ann Deaf. 1985;130:305-314.
80. Zarit SH, Orr NK, Zarit JM. The Hidden Victims of Alzheimer's Disease: Families Under Stress. New York: New York University Press; 1985.
81. Remien RH, Chrisopher R. A family psychoeducational model for long-term rehabilitation: prevention and treatment. Phys Occup Ther Geriatr. 1996;14:2-10.
82. El-Bassel N, Chen DR, Cooper D. Social support and social network profiles among women on methadone. Soc Serv Rev. 1998;72:379-401.
83. Galanter M, Egelko S, de Leon G, et al. A general hospital day program combining peer-led and professional treatment of cocaine abusers. Hosp Community Psychiatry. 1993;44:644-649.
84. Kelly JA, Murphy DA, Washington CD, et al. The effects of HIV/AIDS intervention groups for high-risk women in urban primary health care clinics. Am J Public Health. 1995;84:1918-1922.
85. Mermelstein R, Cohen S, Lichtenstein E, et al. Social support and smoking cessation and maintenance. J Consult Clin Psychol. 1986;54:447-453.
86. Neaigus A, Friedman SR, Curtis R, et al. The relevance of drug injector's social and risk networks for understanding and preventing HIV infection. Soc Sci Med. 1994;38:67-78.
87. Kaskutas LA, Bond J, Humphreys K. Social networks as mediators of the effect of Alcoholics Anonymous. Addiction. 2002;97:891-910.
88. Liepman MR, Nirenberg TD, Begin AM. Evaluation of a program designed to help family and significant others to motivate resistant alcoholics into recovery. Am J Drug Alcohol Abuse. 1984;15:209-221.
89. Longabaugh R. Involvement of support networks in treatment. Recent Dev Alcohol. 2003;16:133-147.
90. Longabaugh R, Wirtz PW, Zweben A, et al. Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction. 1998;9:1313-1333.
91. Sobell MB, Sobell LC, Leo GI. Does enhanced social support improve outcomes for problem drinkers in guided self-change treatment? J Behav Ther Exp Psychiatry. 2000;31:41-54.
92. Szapocznik J, Williams RA. Brief strategic family therapy: twenty-five years of interplay among theory, research and practice in adolescent behavior problems and drug abuse. Clin Child Fam Psychol Rev. 2000;3:117-134.
93. Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall; 1986.
94. Becker MH. The Health Belief Model and Personal Health Behavior. Thorofare, NJ: Charles B. Slack; 1974.
95. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179-211.
96. Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull. 1992;111:455-474.
97. Tuldra A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active anti-retroviral therapy. J Acquir Immune Defic Syndr. 2000;25:221-228.
98. Smith SR, Rublein JC, Marcus C, et al. A medication self-management program to improve adherence to HIV therapy regimens. Patient Educ Couns. 2003;50:187-199.
99. Margolin A, Avants SK,Warburton LA, et al. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003;22:223-228.
100. Cote JK, Godin G. Efficacy of interventions in improving adherence to antiretroviral therapy. Int J STD AIDS. 2005;16:335-343.
101. Blankenship KM, Friedman SR, Dworkin S, et al. Structural interventions: concepts, challenges, and opportunities for research. J Urban Health. 2006;83:59-72.
102. Coates TJ, Szekeres G. A plan for the next generation of HIV prevention research: seven key policy investigative challenges. Am Psychol. 2004;59:747-757.
103. Parker RG, Easton D, Klein CH. Structural barriers and facilitators in HIV prevention: a review of international research. AIDS. 2000;14(Suppl):S22- S32.
104. Ewart CK. Social action theory for a public health psychology. Am Psychol. 1991;46:931-946.
105. McCree DH, Wingood GM, DiClemente R, et al. Religiosity and risky sexual behavior in African-American adolescent females. J Adolesc Health. 2003;33:2-8.
106. Lightfoot M, Rotheram-Borus JJ, Milburn NG, et al. Prevention for HIV-seropositive persons: successive approximation toward a new identity. Behav Modif. 2005;29:227-255.
107. Gore-Fenton C, Rotheram-Borus MJ, Weinhardt LS, et al. The Healthy Living Project: an individually tailored, multidimensional intervention for HIV-infected persons. AIDS Educ Prev. 2005;17(Suppl A):21-39.
108. Gottman J. The roles of conflict management, escalation, and avoidance in marital interactions: a longitudinal view of five styles of couples. J Consult Clin Psychol. 1993;61:6-15.
109. Kurdeck LA. Correlates of relationship satisfaction in cohabiting gay and lesbian couples: integration of contextual, investment, and problem solving models. J Pers Soc Psychol. 1991;61:910-922.
110. Rusbult CE, Verette J, Whitney GA, et al. Accommodation processes in close relationships: theory and preliminary empirical evidence. J Pers Soc Psychol. 1991;60:53-78.
111. Remien RH, Stirratt MJ, Dolezal C, et al. The role of partner support in a successful HIV medication adherence intervention: the SMART Couples Project. Presented at: Annual Meeting of the Society for Behavioral Medicine; 2006; San Francisco.
112. Stirratt MJ, Remien RH, Smith A, et al. The role of HIV serostatus disclosure in antiretroviral adherence. AIDS Behav. 2006;10:483-493.